| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.4 | 0.01 |